In focus
Latest feed
GSK's Bold Gambit: $1.4 Billion Bet on Aiolos Bio for Pulmonary Hypertension Breakthrough
GSK's Bold Move: A $1.8 Billion Bet on the Future of Pulmonary Hypertension Treatment
Electromed: A Closer Look at What Lies Beyond the Immediate Horizon
Legal Battle Heats Up: RFK Jr.'s Former Organization Faces Federal Lawsuit Over Vaccine Claims
Latest headlines
